Upcoming PCSS-O Webinar: "Face the Dragon with Improved Documentation (ASPMN)"

Face the Dragon with Improved Documentation
(ASPMN)

August 23, 2013 1:00 pm - 2:00 pm ET

Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.

            
Webinar Information:

A webinar offered by American Society of Pain Management Nursing (ASPMN).

Objectives: 

1. To facilitate practice improvements by educating practitioners about state licensing board expectations about medical record documentation relating to the use of chronic opioid therapy;

2. To facilitate practice improvements and understanding of the informed consent and patient education process surrounding the chronic opioid therapy treatment plan, using a comparison of poor, average, and good documentation of the same; and

3. To facilitate improved quality of care by providing practitioners with new tools to document patient education on safe use, storage, and disposal of prescription medication, and to properly handle termination of care through discharge and referral, so the patient is not abandoned.       

Date: August 23, 2013

Speaker: Jennifer Bolen, JD – The J. Bolen Group LLC 
Time: 1:00 pm – 2:00 pm ET
                                                                       
To Register: 
https://www3.gotomeeting.com/register/228556966

Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.